This content is only available to 2026 ASCRS Annual Meeting physician registrants
To log in, click the teal "Login" button in the upper right-hand corner of this page. If you are logged in but still do not have access, please check your 2026 Annual Meeting registration.
Refractive treatment for moderate hyperopia in younger patients is limited to surface ablation/LASIK/CLE with associated nuances. We now have reasons to SMILE and avoid the risk of possible haze, long-term dry eyes, loss of accommodation and photic phenomenon.
